Renal involvement in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL): Report of a case with a six-year follow-up

Histology and Histopathology

Volumn 27, Issue 10, 2012, Pages 1307-1314

  Ragno, Michele ^a   Trojano, Luigi ^b   Pianese, Luigi ^a   Boni, Maria Virginia ^a   Silvestri, Serena ^a   Mambelli, Vladimiro ^a   Lorenzi, Teresa ^c   Scarpelli, Marina ^c   Morroni, Manrico ^c  

^a Mazzoni Hospital   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

CADASIL; Kidney; Light microscopy; Skin; Transmission electron microscopy

Indexed keywords

NOTCH RECEPTOR; NOTCH3 PROTEIN, HUMAN;

ARTICLE; CADASIL; CASE REPORT; GENETICS; HUMAN; KIDNEY; MALE; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; SKIN; TIME; TRANSMISSION ELECTRON MICROSCOPY; VASCULAR SMOOTH MUSCLE;

CADASIL; HUMANS; KIDNEY; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; RECEPTORS, NOTCH; SKIN; TIME FACTORS;

EID: 84867522659     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Alberts M.J. and Tournier-Lasserve E. (2005). Update on the genetics of stroke and cerebrovascular disease. Stroke 36, 179-181.
2. Baudrimont M., Dubas F., Joutel A., Tournier-Lasserve E. and Bousser M-G. (1993). Autosomal dominant leukoencephalopathy and subcortical ischemic stroke. A clinicopathological study. Stroke 24, 122-125.
3. Belin de Chantemèle E.J., Retailleau K., Pinaud F., Vessières E., Bocquet A., Guihot A.L., Lemaire B., Domenga V., Baufreton C., Loufrani L., Joutel A. and Henrion D. (2008). Notch3 is a major regulator of vascular tone in cerebral and tail resistance arteries. Arterioscler. Thromb. Vasc. Biol. 28, 2216-2224.
4. Bergmann M., Ebke M., Yuan Y., Brück W., Mugler M. and Schwendemann G. (1996). Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL): a morphological study of a German family. Acta Neuropathol. 92, 341-350.
5. Boulos N., Helle F., Dussaule J.C., Placier S., Milliez P., Djudjaj S., Guerrot D., Joutel A., Ronco P., Boffa J.J. and Chatziantoniou C. (2011). Notch3 is essential for regulation of the renal vascular tone. Hypertension 57, 1176-1182.
6. Cappelli A., Ragno M., Cacchiò G., Scarcella M., Staffolani P. and Pianese L. (2009). High recurrence of the R1006C Notch3 mutation in central Italian patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Neurosci. Lett. 462, 176-178.
7. Chabriat H., Vahedi K., Iba-Zizen M.T., Joutel A., Nibbio A., Nagy T.G., Krebs M.O., Jul J., Dubois B., Ducrocq X., Levasseur M., Mas J.L., Lyon-Caen O., Tournier-Lasserve E. and Bousser M.G. (1995). Clinical spectrum of CADASIL: a study of 7 families. Lancet 346, 934-939.
8. Cifkova R., Erdine S., Fagard R., Farsang C., Heagerty A.M., Kiowski W., Kjeldsen S., Lüscher T., Mallion J.M., Mancia G., Poulter N., Rahn K.H., Rodicio J.L., Ruilope L.M., van Zwieten P., Waeber B., Williams B. and Zanchetti A. (2003). ESH/ESC Hypertension Guidelines Committee. Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines. J. Hypertens. 21, 1779-1786.
9. D'Agati V.D., Jennette J.C. and Silva F.G. (2005). Normal renal anatomy, histology, and development. In: Atlas of nontumor pathology. Non-neoplastic kidney diseases. D'Agati V.D., Jennette J.C. and Silva F.G. (eds). ARP Press, Silver Spring. Maryland. pp 1-18.
10. Dichgans M. (2007). Genetics of ischaemic stroke. Lancet Neurol. 6, 149-161.
11. Domenga V., Fardoux P., Lacombe P., Monet M., Maciazek J., Krebs L.T., Klonjkowski B., Berrou E., Mericskay M., Li Z., Tournier-Lasserve E., Gridley T. and Joutel A. (2004). Notch3 is required for arterial identity and maturation of vascular smooth muscle cells. Genes Dev. 18, 2730-2735.
12. Guerrot D., Francois A., Boffa J.J., Boulos N., Hanoy M., Legallicier B., Triquenot-Bagan A., Guyant-Marechal L., Laquerriere A., Freguin-Bouilland C., Ronco P. and Godin M. (2008). Nephroangiosclerosis in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: is NOTCH3 mutation the common culprit? Am. J. Kidney Dis. 52, 340-345.
13. Ishiko A., Shimizu A., Nagata E., Takahashi K., Tabira T. and Suzuki N. (2006). Notch3 ectodomain is a major component of granular osmiophilic material (GOM) in CADASIL. Acta Neuropathol. 112, 333-339.
14. Joutel A. (2011). Pathogenesis of CADASIL: transgenic and knock-out mice to probe function and dysfunction of the mutated gene, Notch3, in the cerebrovasculature. Bioessays 33, 73-80.
15. Joutel A., Corpechot C., Ducros A., Vahedi K., Chabriat H., Mouton P., Alamowitch S., Domenga V., Cécillon M., Maréchal E., Maciazek J., Vayssière C., Cruaud C., Cabanis E.A., Ruchoux M.M., Weissenbach J., Bach J.F., Bousser M.G. and Tournier-Lasserve E. (1996). Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 383, 707-710.
16. Joutel A., Vahedi K., Corpechot C., Troesch A., Chabriat H., Vayssière C., Cruaud C., Maciazek J., Weissenbach J., Bousser M.G., Bach J.F. and Tournier-Lasserve E. (1997). Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet 350, 1511-1515.
17. Joutel A., Andreux F., Gaulis S., Domenga V., Cécillon M., Battail N., Piga N., Chapon F., Godfrain C. and Tournier-Lasserve E. (2000). The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. J. Clin. Invest. 105, 597-605.
18. Joutel A., Favrole P., Labauge P., Chabriat H., Lescoat C., Andreux F., Domenga V., Cécillon M., Vahedi K., Ducros A., Cave-Riant F., Bousser M.G. and Tournier-Lasserve E. (2001). Skin biopsy immunostaining with a Notch3 monoclonal antibody for CADASIL diagnosis. Lancet 358, 2049-2051.
19. Kusaba T., Hatta T., Kimura T., Sonomura K., Tanda S., Kishimoto N., Kameyama H., Okigaki M., Mori Y., Ishigami N., Mizuno T., Nakagawa M. and Matsubara H. (2007). Renal involvement in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Clin. Nephrol. 67, 182-187.
20. Mayer M., Straube A., Bruening R., Uttner J., Pongratz D., Gasser T., Dichgans M. and Muller-Hocker M. (1999). Muscle and skin biopsies are a sensitive diagnostic tool in the diagnosis of CADASIL. J. Neurol. 246, 526-532.
21. Miao Q., Paloneva T., Tuominen S., Pöyhönen M., Tuisku S., Viitanen M. and Kalimo H. (2004). Fibrosis and stenosis of the long penetrating cerebral arteries: the cause of the white matter pathology in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Brain Pathol. 14, 358-364.
22. Peters N., Opherk C., Bergmann T., Castro M., Herzog J. and Dichgans M. (2005). Spectrum of mutations in biopsy-proven CADASIL: implications for diagnostic strategies. Arch. Neurol. 62, 1091-1094.
23. Rafalowska J., Fidzianska A., Dziewulska D., Podlecka A., Szpak G.M. and Kwiecinski H. (2004). CADASIL or CADVaSIL? Neuropathology 24, 16-20.
24. Ragno M., Fabrizi G.M., Cacchiò G., Scarcella M., Sirocchi G., Selvaggio F., Taioli F., Ferrarini M. and Trojano L. (2006). Two novel Italian CADASIL families from Central Italy with mutation CGC-TGC at codon 1006 in the exon 19 Notch3 gene. Neurol. Sci. 27, 252-256.
25. Reisberg B., Ferris S.H., De Leon M.J. and Crook T. (1982). The Global Deterioration Scale for assessment of primary degenerative dementia. Am. J. Psychiatry 139, 1136-1139.
26. Ruchoux M.M. and Maurage C.A. (1998). Endothelial changes in muscle and skin biopsies in patients CADASIL. Neuropathol. Appl. Neurobiol. 24, 60-65.
27. Ruchoux M.M., Chabriat H., Bousser M.G., Baudrimont M. and Tournier-Lasserve E. (1994). Presence of ultrastructural arterial lesions in muscle and skin vessels of patients with CADASIL. Stroke 25, 2291-2292.
28. Ruchoux M.M., Guerouaou D., Vandenhaute B., Pruvo J.P., Vermersch P. and Leys D. (1995). Systemic vascular smooth muscle cell impairment in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Acta Neuropathol. 89, 500-512.
29. Scheltens P., Barkhof F., Leys D., Pruvo J.P., Nauta J.J., Vermersch P., Steinling M. and Valk J. (1993). A semiquantitative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J. Neurol. Sci. 114, 7-12.
30. Tikka S., Mykkänen K., Ruchoux M.M., Bergholm R., Junna M., Pöyhönen M., Yki-Järvinen H., Joutel A., Viitanen M., Baumann M. and Kalimo H. (2009). Congruence between NOTCH3 mutations and GOM in 131 CADASIL patients. Brain 132, 933-939.
31. Tournier-Lasserve E., Joutel A., Melki J., Weissenbach J., Lathrop G.M., Chabriat H., Mas J.L., Cabanis E.A., Baudrimont M., Maciazek J., Bach M.A. and Bousser M.G. (1993). Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12. Nat. Genet. 3, 256-259.
32. Wang Z., Yuan Y., Zhang W., Lv H., Hong D., Chen B., Liu Y., Luan X., Xie S. and Wu S. (2011). Notch3 mutations and clinical features in 33 mainland Chinese families with CADASIL. J. Neurol. Neurosurg. Psychiatry 82, 534-539.